A new study provides striking evidence of how point-of-care testing can transform antibiotic prescribing practices. The data tells a compelling story: baseline antibiotic prescribing rates of 87.6% for acute respiratory infections dropped to 32.5% when clinics implemented C-reactive protein and serum amyloid A testing with clinical decision support. In contrast, control clinics showed minimal improvement, declining only to 83.1%.
This 55-percentage-point difference represents the largest reduction in antibiotic overprescribing documented in a rural primary care setting using point-of-care testing. The trial, conducted across 76 village clinics in Anhui Province over two years, enrolled nearly 5,000 patients and demonstrated that biomarker-guided approaches can effectively combat antimicrobial resistance without compromising patient safety. These findings suggest significant potential for scaling similar interventions globally.
Read the full article on GMJ Newsroom.
Was this article helpful?
